United States· US:68788-8130_8879bafb-be30-45f9-bc9d-20ba8bc803bb
Neomycin and Polymyxin B Sulfates and Hydrocortisone
A medicinal product containing neomycin sulfate; polymyxin b sulfate; hydrocortisone, registered in United States by Preferred Pharmaceuticals Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- NEOMYCIN SULFATE; POLYMYXIN B SULFATE; HYDROCORTISONE
- Manufacturer
- Preferred Pharmaceuticals Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1168788-8130-1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ece20a2a-6d31-4537-a867-68ed4461372e GET /v1/drugs/ece20a2a-6d31-4537-a867-68ed4461372e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "AURICULAR (OTIC)",
"source": "ndc",
"strength": "3.5; 10000; 10",
"substance": "NEOMYCIN SULFATE; POLYMYXIN B SULFATE; HYDROCORTISONE",
"productndc": "68788-8130",
"dosage_form": "SUSPENSION",
"dea_schedule": null,
"strength_unit": "mg/mL; [USP'U]/mL; mg/mL",
"application_number": "ANDA062488",
"marketing_category": "ANDA"
}See everything about neomycin sulfate; polymyxin b sulfate; hydrocortisone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.